Trials / Unknown
UnknownNCT03643185
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis and Its Relevance to Severity and Exacerbation.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main aim of this study is to determine whether the levels of different inflammatory cytokines in the serum and BALF (bronchoalveolar lavage fluid) are relative to the severity and exacerbations of ABPA (allergic bronchopulmonary aspergillosis).
Detailed description
The study would record patients' medical data at baseline and follow them up for different period of time. Updated data would be recorded and blood( or BALF) of the patients would be drawn for tests or stored as whole blood or serum at -80℃ when patients visit the hospital. Then the cytokine (A panel set by the manufacturer) of the serum and BALF would be tested . The secretion ability of peripheral blood mononuclear cells would also be verified. The investigators would then analyze the data and see if any cytokine is relative to the exacerbation or other indicators of the severity of ABPA.
Conditions
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2021-05-04
- Completion
- 2021-05-04
- First posted
- 2018-08-22
- Last updated
- 2021-03-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03643185. Inclusion in this directory is not an endorsement.